| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |